Nextcure Inc. buy BiotechBee
Start price
04.02.23
/
50%
€1.51
Target price
31.12.25
€2.50
Performance (%)
-3.93%
End price
05.05.23
€1.46
Summary
This prediction ended on 05.05.23 with a price of €1.46. With a performance of -3.93%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has a follow-up prediction for Nextcure Inc. where he still thinks Nextcure Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Nextcure Inc. | - | - | - |
iShares Core DAX® | -2.023% | -3.140% | 10.499% |
iShares Nasdaq 100 | 4.625% | 8.753% | 34.939% |
iShares Nikkei 225® | -2.088% | -0.980% | 3.292% |
iShares S&P 500 | 2.398% | 4.677% | 27.998% |
According to BiotechBee what are the pros and cons of Nextcure Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Nextcure Inc. diskutieren
Buy mit Kursziel 2,5
In the thread Trading Nextcure Inc.
Buy beendet
Current prediction by BiotechBee for Nextcure Inc.
Nextcure Inc.
Start price
Target price
Perf. (%)
€1.24
10.12.23
10.12.23
€3.00
31.07.25
31.07.25
20.97%
14.06.24
14.06.24
Could be very worthwhile Investment >20% year